We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Deal plague

4 Mar 2020 By Lauren Silva Laughlin

Even without market volatility and a virulent new disease, rapid shifts in U.S. merger rules have dealmakers on edge. Wall Street’s M&A bankers and lawyers are convening for their annual confab despite the coronavirus, hoping to learn to read more into the Washington tea leaves.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)